HHQ16 is an orally active derivative of Astragaloside IV (HY-N0431). HHQ16 effectively reverses infarction-induced hypertrophy and heart failure by targeted degrading lnc4012/lnc9456 and antagonizing their effects on G3BP2/NF-kappaB signaling[1].
Molecular Weight:
510.70
CAS Number:
[2620471-66-9]
Formula:
C30H48F2O4
Target:
Drug Derivative
Application Notes:
MCE Product type: Oligonucleotides
* VAT and and shipping costs not included. Errors and price changes excepted
